- News
- Profit Outlook
Tag:
Profit Outlook
-
UnitedHealth Group reported quarterly earnings on Tuesday that exceeded Wall Street expectations and raised its full-year profit forecast, as the company kept costs under control and benefited from improved government payments for its health insurance operations.21 Apr 2026-16:14
-
-
European plane maker Airbus said Thursday it plans to deliver a record number of commercial aircraft in 2026, citing strong demand and a sharp rise in profit in 2025.19 Feb 2026-10:59
-
-
Siemens has raised its full-year profit outlook after delivering stronger-than-expected results in the first quarter of its 2026 fiscal year, signaling resilient demand across its industrial businesses.12 Feb 2026-10:15
-
-
Uber Technologies on Wednesday forecast first-quarter profit below market expectations and reported fourth-quarter results that also missed estimates, pressured by higher taxes and a shift toward more affordable ride options aimed at boosting bookings.04 Feb 2026-16:37
-
-
Japan’s Nintendo on Tuesday left its annual operating profit forecast unchanged at 370 billion yen ($2.4 billion), representing an increase of nearly one-third compared with the previous financial year.03 Feb 2026-10:47
-
-
UnitedHealth Group on Tuesday forecast 2026 adjusted profit slightly above Wall Street expectations, signaling that tighter cost-control efforts under CEO Stephen Hemsley are starting to show results.27 Jan 2026-15:20
-
-
Exxon Mobil has upgraded its long-term financial outlook, forecasting stronger earnings and cash flow growth through 2030 without raising capital spending.09 Dec 2025-16:17
-
-
Spotify forecast fourth-quarter profit above Wall Street expectations on Tuesday, betting on robust user growth and a boost from price hikes in the crucial holiday season.
04 Nov 2025-15:30 -
-
Shares in Porsche dropped 6.2% in early Frankfurt trading on Monday after the luxury carmaker delayed the rollout of several all-electric models and slashed its 2025 profit forecast.22 Sep 2025-10:58
-
-
Pfizer has raised its full-year 2025 adjusted earnings forecast after posting stronger-than-expected second-quarter results and making significant progress on cost-cutting. The pharmaceutical giant now anticipates earnings of $2.90 to $3.10 per share, up from its previous estimate of $2.80 to $3. It also reaffirmed its full-year revenue forecast of $61 billion to $64 billion.05 Aug 2025-16:33
-